Otoraplin Protein (OTOR)

Produktnummer ABIN935700

Produktdetails

Target: Otoraplin (OTOR)

Protein-Typ: Recombinant

Spezies: Human

Quelle: Escherichia coli (E. coli)

Sequenz: MVHGIFMDRL ASKKLCADDE CVYTISLASA QEDYNAPDCR FINVKKGQQI YVYSKLVKEN GAGEFWAGS VYGDGQDEMG VVGYFPRNLV KEQRVYQEAT KEVPTTDIDF FCE

Produktmerkmale: Purified recombinant Human OTOR protein
Expression System: E.coli

Reinheit: > 98 % pure

Endotoxin-Niveau: < 0.1 ng per µg (1 EU/µg).

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Buffer: Supplied as a lyophilized powder.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C until reconstitution. Following reconstitution aliquot and freeze at -20 °C for long term storage.

Antigendetails

Target: Otoraplin (OTOR)

Andere Bezeichnung: OTOR (OTOR Produkte)

Hintergrund: OTOR, also called Otoraplin and MIAL, is a secreted cytokine and a member of the MIA/OTOR family. Members of this family which also includes MIA, MIA2, and TANGO share a Src homology-3 (SH3)-like domain. OTOR is predominantly expressed in the cochlea of the inner-ear and to a lesser extent in fetal brain and in some cartilage tissues. OTOR appears to be involved in early chondrogenesis of the otic capsule, which is required for normal inner ear development and auditory function.
Alternative Names: MIAL protein, Otoraplin protein

Molekulargewicht: 12.7 kDa

Pathways: Sensory Perception of Sound, Regulation of Carbohydrate Metabolic Process